Pancreatic cancer: a glimmer of hope

被引:1
作者
Nagendram, Sathyan [1 ,2 ]
Bhattacharya, Satyajit [1 ]
机构
[1] London Clin, HPB Surg Unit, London, England
[2] Barts Canc Inst, Ctr Tumour Biol, London, England
关键词
ADJUVANT CHEMOTHERAPY; GEMCITABINE; MANAGEMENT; FOLFIRINOX; RESECTION; SURGERY;
D O I
10.1002/tre.904
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Pancreatic cancer carries a very poor prognosis, with five-year survival currently approaching 10%. Late presentation, lack of effective treatment options and a tumour microenvironment that subverts immune mechanisms are some of the reasons behind this. Here the authors discuss how advances in our understanding of tumour biology, identification and surveillance of high-risk groups, improvements in surgical outcomes and the availability of new chemotherapeutic options give us grounds for optimism.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 35 条
[1]  
[Anonymous], About Us
[2]   Update on the management of pancreatic cancer: Surgery is not enough [J].
Ansari, Daniel ;
Gustafsson, Adam ;
Andersson, Roland .
WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (11) :3157-3165
[3]   A Phase II Randomized, Double-Blind, Placebo-Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First-Line Treatment of Pancreatic Adenocarcinoma [J].
Benson, Al B., III ;
Wainberg, Zev A. ;
Hecht, J. Randolph ;
Vyushkov, Dmitry ;
Dong, Hua ;
Bendell, Johanna ;
Kudrik, Fred .
ONCOLOGIST, 2017, 22 (03) :241-+
[4]  
Bhattacharya S., 2018, BAILEY LOVES SHORT P
[5]   Cold Tumors: A Therapeutic Challenge for Immunotherapy [J].
Bonaventura, Paola ;
Shekarian, Tala ;
Alcazer, Vincent ;
Valladeau-Guilemond, Jenny ;
Valsesia-Wittmann, Sandrine ;
Amigorena, Sebastian ;
Caux, Christophe ;
Depil, Stephane .
FRONTIERS IN IMMUNOLOGY, 2019, 10
[6]   Prehabilitation prior to surgery for pancreatic cancer: A systematic review [J].
Bundred, James R. ;
Kamarajah, Sivesh K. ;
Hammond, John S. ;
Wilson, Colin H. ;
Prentis, James ;
Pandanaboyana, Sanjay .
PANCREATOLOGY, 2020, 20 (06) :1243-1250
[7]  
Cancer Research UK, Pancreatic cancer statistics
[8]   Epigenetic Landscape in Pancreatic Ductal Adenocarcinoma: On the Way to Overcoming Drug Resistance? [J].
Ciernikova, Sona ;
Earl, Julie ;
Garcia Bermejo, Maria Laura ;
Stevurkova, Viola ;
Carrato, Alfredo ;
Smolkova, Bozena .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (11) :11-17
[9]   FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer [J].
Conroy, T. ;
Hammel, P. ;
Hebbar, M. ;
Ben Abdelghani, M. ;
Wei, A. C. ;
Raoul, J. -L. ;
Chone, L. ;
Francois, E. ;
Artru, P. ;
Biagi, J. J. ;
Lecomte, T. ;
Assenat, E. ;
Faroux, R. ;
Ychou, M. ;
Volet, J. ;
Sauvanet, A. ;
Breysacher, G. ;
Di Fiore, F. ;
Cripps, C. ;
Kavan, P. ;
Texereau, P. ;
Bouhier-Leporrier, K. ;
Khemissa-Akouz, F. ;
Legoux, J. -L. ;
Juzyna, B. ;
Gourgou, S. ;
O'Callaghan, C. J. ;
Jouffroy-Zeller, C. ;
Rat, P. ;
Malka, D. ;
Castan, F. ;
Bachet, J. -B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (25) :2395-2406
[10]   FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer [J].
Conroy, Thierry ;
Desseigne, Francoise ;
Ychou, Marc ;
Bouche, Olivier ;
Guimbaud, Rosine ;
Becouarn, Yves ;
Adenis, Antoine ;
Raoul, Jean-Luc ;
Gourgou-Bourgade, Sophie ;
de la Fouchardiere, Christelle ;
Bennouna, Jaafar ;
Bachet, Jean-Baptiste ;
Khemissa-Akouz, Faiza ;
Pere-Verge, Denis ;
Delbaldo, Catherine ;
Assenat, Eric ;
Chauffert, Bruno ;
Michel, Pierre ;
Montoto-Grillot, Christine ;
Ducreux, Michel .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (19) :1817-1825